Charles Schwab’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54.8M | Buy |
196,558
+16,169
| +9% | +$4.66M | 0.01% | 1094 |
|
|
2025
Q4 | $54.7M | Buy |
180,389
+423
| +0.2% | +$132K | 0.01% | 1093 |
|
|
2025
Q3 | $50.5M | Sell |
179,966
-17,654
| -9% | -$4.8M | 0.01% | 1151 |
|
|
2025
Q2 | $47.7M | Sell |
197,620
-5,560
| -3% | -$1.31M | 0.01% | 1140 |
|
|
2025
Q1 | $49.5M | Buy |
203,180
+11,313
| +6% | +$3.4M | 0.01% | 1077 |
|
|
2024
Q4 | $63M | Buy |
191,867
+7,552
| +4% | +$2.56M | 0.01% | 961 |
|
|
2024
Q3 | $61.7M | Sell |
184,315
-46,341
| -20% | -$14.7M | 0.01% | 966 |
|
|
2024
Q2 | $63M | Buy |
230,656
+7,215
| +3% | +$2.1M | 0.01% | 903 |
|
|
2024
Q1 | $77.3M | Buy |
223,441
+9,207
| +4% | +$3.03M | 0.02% | 739 |
|
|
2023
Q4 | $69.2M | Buy |
214,234
+10,040
| +5% | +$3.15M | 0.02% | 760 |
|
|
2023
Q3 | $73.2M | Buy |
204,194
+2,645
| +1% | +$1.02M | 0.02% | 652 |
|
|
2023
Q2 | $76.4M | Buy |
201,549
+1,133
| +0.6% | +$461K | 0.02% | 625 |
|
|
2023
Q1 | $96M | Buy |
200,416
+4,526
| +2% | +$2.12M | 0.03% | 516 |
|
|
2022
Q4 | $82.4M | Buy |
195,890
+11,543
| +6% | +$4.66M | 0.03% | 557 |
|
|
2022
Q3 | $76.9M | Buy |
184,347
+3,824
| +2% | +$1.91M | 0.03% | 538 |
|
|
2022
Q2 | $89.4M | Buy |
180,523
+6,597
| +4% | +$3.44M | 0.03% | 498 |
|
|
2022
Q1 | $98M | Buy |
173,926
+5,416
| +3% | +$3.26M | 0.03% | 522 |
|
|
2021
Q4 | $127M | Buy |
168,510
+4,735
| +3% | +$3.54M | 0.04% | 433 |
|
|
2021
Q3 | $122M | Buy |
163,775
+5,024
| +3% | +$3.76M | 0.04% | 411 |
|
|
2021
Q2 | $102M | Buy |
158,751
+4,227
| +3% | +$2.57M | 0.03% | 480 |
|
|
2021
Q1 | $88.3M | Buy |
154,524
+415
| +0.3% | +$246K | 0.03% | 511 |
|
|
2020
Q4 | $89.8M | Sell |
154,109
-4,063
| -3% | -$2.31M | 0.04% | 457 |
|
|
2020
Q3 | $81.5M | Buy |
158,172
+2,144
| +1% | +$1.09M | 0.04% | 420 |
|
|
2020
Q2 | $70.4M | Buy |
156,028
+27,911
| +22% | +$12.3M | 0.03% | 480 |
|
|
2020
Q1 | $44.9M | Buy |
128,117
+1,935
| +2% | +$711K | 0.03% | 570 |
|
|
2019
Q4 | $46.7M | Buy |
126,182
+673
| +0.5% | +$237K | 0.03% | 668 |
|
|
2019
Q3 | $41.8M | Buy |
125,509
+10,616
| +9% | +$3.46M | 0.02% | 681 |
|
|
2019
Q2 | $35.9M | Buy |
114,893
+820
| +0.7% | +$246K | 0.02% | 757 |
|
|
2019
Q1 | $34.9M | Buy |
114,073
+7,945
| +7% | +$2.14M | 0.02% | 750 |
|
|
2018
Q4 | $24.6M | Buy |
106,128
+1,642
| +2% | +$441K | 0.02% | 851 |
|
|
2018
Q3 | $32.7M | Sell |
104,486
-30,361
| -23% | -$9.42M | 0.02% | 789 |
|
|
2018
Q2 | $38.9M | Buy |
134,847
+6,460
| +5% | +$1.78M | 0.03% | 622 |
|
|
2018
Q1 | $32.1M | Buy |
128,387
+5,533
| +5% | +$1.41M | 0.03% | 698 |
|
|
2017
Q4 | $29.3M | Buy |
122,854
+4,332
| +4% | +$1.05M | 0.02% | 718 |
|
|
2017
Q3 | $26.3M | Buy |
118,522
+3,304
| +3% | +$744K | 0.02% | 715 |
|
|
2017
Q2 | $26.1M | Buy |
115,218
+2,070
| +2% | +$451K | 0.02% | 679 |
|
|
2017
Q1 | $22.6M | Buy |
113,148
+9,164
| +9% | +$1.77M | 0.02% | 750 |
|
|
2016
Q4 | $19M | Buy |
103,984
+6,918
| +7% | +$1.18M | 0.02% | 787 |
|
|
2016
Q3 | $15.9M | Buy |
97,066
+9,162
| +10% | +$1.39M | 0.02% | 832 |
|
|
2016
Q2 | $12.6M | Buy |
87,904
+2,559
| +3% | +$365K | 0.02% | 915 |
|
|
2016
Q1 | $11.7M | Buy |
85,345
+5,188
| +6% | +$681K | 0.02% | 941 |
|
|
2015
Q4 | $11.1M | Sell |
80,157
-1,157
| -1% | -$160K | 0.02% | 945 |
|
|
2015
Q3 | $10.9M | Buy |
81,314
+5,291
| +7% | +$762K | 0.02% | 936 |
|
|
2015
Q2 | $11.4M | Sell |
76,023
-59,151
| -44% | -$8.46M | 0.02% | 924 |
|
|
2015
Q1 | $18.3M | Sell |
135,174
-19,176
| -12% | -$2.38M | 0.03% | 602 |
|
|
2014
Q4 | $18.6M | Sell |
154,350
-9,600
| -6% | -$1.1M | 0.03% | 545 |
|
|
2014
Q3 | $18.6M | Buy |
163,950
+9,726
| +6% | +$1.15M | 0.03% | 517 |
|
|
2014
Q2 | $18.5M | Buy |
154,224
+1,457
| +1% | +$178K | 0.03% | 511 |
|
|
2014
Q1 | $19.6M | Buy |
152,767
+14,943
| +11% | +$1.92M | 0.04% | 471 |
|
|
2013
Q4 | $17M | Buy |
137,824
+4,821
| +4% | +$587K | 0.03% | 484 |
|
|
2013
Q3 | $15.8M | Buy |
133,003
+21,846
| +20% | +$2.58M | 0.03% | 468 |
|
|
2013
Q2 | $12.6M | Buy |
+111,157
| New | +$13M | 0.03% | 498 |
|
Other funds holding BIO
VCM
VPM
AI
